Department of Neuromuscular Diseases, UCL Queen's Square Institute of Neurology, Queen's Square House, Queen's Square, London, WC1N 3BG, UK.
J Neurol. 2019 Feb;266(2):533-544. doi: 10.1007/s00415-018-9076-4. Epub 2018 Oct 3.
Spinocerebellar ataxia (SCA) is a heterogeneous group of neurodegenerative ataxic disorders with autosomal dominant inheritance. We aim to provide an update on the recent clinical and scientific progresses in SCA where numerous novel genes have been identified with next-generation sequencing techniques. The main disease mechanisms of these SCAs include toxic RNA gain-of-function, mitochondrial dysfunction, channelopathies, autophagy and transcription dysregulation. Recent studies have also demonstrated the importance of DNA repair pathways in modifying SCA with CAG expansions. In addition, we summarise the latest technological advances in detecting known and novel repeat expansion in SCA. Finally, we discuss the roles of antisense oligonucleotides and RNA-based therapy as potential treatments.
脊髓小脑共济失调(SCA)是一组具有常染色体显性遗传的异质性神经退行性共济失调疾病。我们旨在提供 SCA 最近的临床和科学进展的最新信息,其中许多新的基因已经通过下一代测序技术被鉴定出来。这些 SCA 的主要疾病机制包括毒性 RNA 获得功能、线粒体功能障碍、通道病、自噬和转录失调。最近的研究还表明,DNA 修复途径在修饰具有 CAG 扩展的 SCA 方面的重要性。此外,我们总结了在检测 SCA 中已知和新型重复扩展方面的最新技术进展。最后,我们讨论了反义寡核苷酸和基于 RNA 的治疗作为潜在治疗方法的作用。